Apogee Therapeutics, Inc.(NASDAQ:APGE) 
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subc...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 33.53
H 33.66
L 30.81
C 32.32
V 1,079,453
10EMA 32.32
20EMA 32.32
60EMA 32.32
120EMA 32.32
250EMA 32.32